About Olaris
Olaris is a company based in Waltham (United States) founded in 2014 by Liz Oday.. Olaris has raised $62.5 thousand across 5 funding rounds from investors including LabCorp, Bruker and The Michael J. Fox Foundation. The company has 9 employees as of December 31, 2022. Olaris offers products and services including Cerebro Services. Olaris operates in a competitive market with competitors including Denali Therapeutics, Poseida Therapeutics, Castle Biosciences, Juno Therapeutics and Personalis, among others.
- Headquarter Waltham, United States
- Employees 9 as on 31 Dec, 2022
- Founders Liz Oday
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Olaris, Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$62.5 K (USD)
in 5 rounds
-
Latest Funding Round
-
Investors
LabCorp
& 9 more
-
Employee Count
9
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Olaris
Olaris offers a comprehensive portfolio of products and services, including Cerebro Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Offers metabolomics-based tools for identifying biomarkers of response in patients.
Unlock access to complete
Unlock access to complete
Funding Insights of Olaris
Olaris has successfully raised a total of $62.5K across 5 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Last Round
-
First Round
First Round
(01 Jun 2018)
- Investors Count 10
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2025 | Amount | Series B - Olaris | Valuation |
investors |
|
| Apr, 2025 | Amount | Series B - Olaris | Valuation |
investors |
|
| Feb, 2020 | Amount | Grant - Olaris | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Olaris
Olaris has secured backing from 10 investors, including institutional, angel, and venture fund investors. Prominent investors backing the company include LabCorp, Bruker and The Michael J. Fox Foundation. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on AI, healthcare, life science, B2B enterprise, and technology sectors
|
Founded Year | Domain | Location | |
|
Venture capital investing and portfolio management services for accredited investors.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Olaris
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Olaris
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Olaris Comparisons
Competitors of Olaris
Olaris operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Denali Therapeutics, Poseida Therapeutics, Castle Biosciences, Juno Therapeutics and Personalis, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Neurodegenerative disease therapies are developed for Alzheimer's, ALS, and Parkinson's.
|
|
| domain | founded_year | HQ Location |
Developer of gene therapies for treating cancer and liver orphan disease by using gene editing technologies
|
|
| domain | founded_year | HQ Location |
Precision diagnostic and prognostic tests are developed by Castle Biosciences.
|
|
| domain | founded_year | HQ Location |
CAR T-cell and T-cell receptor immunotherapies for cancer are developed.
|
|
| domain | founded_year | HQ Location |
Genomic sequencing and diagnosis software is provided for healthcare.
|
|
| domain | founded_year | HQ Location |
Therapeutics for aging diseases are developed by targeting senescent cells.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Olaris
Frequently Asked Questions about Olaris
When was Olaris founded?
Olaris was founded in 2014 and raised its 1st funding round 4 years after it was founded.
Where is Olaris located?
Olaris is headquartered in Waltham, United States. It is registered at Waltham, Massachusetts, United States.
Who is the current CEO of Olaris?
Liz Oday is the current CEO of Olaris. They have also founded this company.
Is Olaris a funded company?
Olaris is a funded company, having raised a total of $62.5K across 5 funding rounds to date.
How many employees does Olaris have?
As of Dec 31, 2022, the latest employee count at Olaris is 9.
What does Olaris do?
Olaris was founded in 2014 and is headquartered in Waltham, United States. In-vitro diagnostics are developed by the company for oncology, solid-organ transplantation, and neurodegeneration. A high-throughput metabolomics platform integrated with machine learning is utilized to identify metabolite signatures. These tools support precision medicine applications within the biotechnology sector. Operations focus on diagnostic solutions for clinical needs in these therapeutic areas.
Who are the top competitors of Olaris?
Olaris's top competitors include Juno Therapeutics, Personalis and Poseida Therapeutics.
What products or services does Olaris offer?
Olaris offers Cerebro Services.
Who are Olaris's investors?
Olaris has 10 investors. Key investors include LabCorp, Bruker, The Michael J. Fox Foundation, Robert Carpenter, and Innospark.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.